Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1.
Masuda T, Fujitaka K, Suzuki T, Hamai K, Matsumoto N, Matsumura M, Isoyama S, Ueno S, Mito M, Yamaguchi K, Sakamoto S, Kawano R, Masuda K, Nishino R, Ishikawa N, Yamasaki M, Hattori N.
Masuda T, et al. Among authors: nishino r.
Thorac Cancer. 2022 Jun;13(11):1611-1618. doi: 10.1111/1759-7714.14428. Epub 2022 Apr 30.
Thorac Cancer. 2022.
PMID: 35488720
Free PMC article.
Clinical Trial.